Table 3b. Clinical characteristics of the 3 patients relapsed after treatment.
| No | Preoperative β-HCG (IU/L) | Surgical mode | Tumor size (cm) | Postoperative β-HCG (IU/L) | Postoperative chemotherapy (regimen*n.) | Time to recurrence (months) | Recurrent site | Recurrent treatment | Status (months) |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 120 | Laparotomy | 3.3 | 21 | EMA/CO*5 | 6 | Uterus, brain, lung | Chemotherapy | DOD (16) |
| 2 | 10.5 | Laparotomy | 5.6 | 0.6 | EMA/CO*3 | 3 | Uterus, lung | Chemotherapy, pulmonary lobectomy | NED (7) |
| 3 | 1.6 | Laparotomy | 5.2 | 0 | EMA/CO*3 | 3, 12, 26 | Uterus, lung | Chemotherapy, hysterectomy | NED (45) |
Abbreviations: DOD, dead of disease; NED, no evidence of disease.